{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:09Z","timestamp":1791308829817,"version":"4.3.1"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Primary hyperparathyroidism is a common endocrine disorder caused by parathyroid gland enlargement and excessive parathyroid hormone (PTH) secretion. However, the precise mechanisms of tumorigenesis of the parathyroids are unknown. Here we have investigated the roles of transforming growth factor (TGF)-\u03b2 and menin, the product of the multiple endocrine neoplasia type 1 (Men1) gene, in the proliferation and PTH production of parathyroid cells from either patients with secondary hyperparathyroidism or Men1. TGF-\u03b2 was expressed in the parathyroid endocrine cells. Addition of TGF-\u03b2 to parathyroid cells from patients with secondary hyperparathyroidism inhibited their proliferation and PTH secretion. These responses to TGF-\u03b2 were lost when menin was specifically inactivated by antisense oligonucleotides. Moreover, TGF-\u03b2 did not affect the proliferation and PTH production of parathyroid cells from a Men1 patient. These results indicate that menin is required for TGF-\u03b2 action in the parathyroid. We conclude that TGF-\u03b2 is an important autocrine\/paracrine negative regulator of parathyroid cell proliferation and PTH secretion and that loss of TGF-\u03b2 signaling due to menin inactivation contributes to parathyroid tumorigenesis.<\/jats:p>","DOI":"10.1158\/0008-5472.can-03-3334","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:37:44Z","timestamp":1127255864000},"page":"2222-2228","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Menin Inactivation Leads to Loss of Transforming Growth Factor \u03b2 Inhibition of Parathyroid Cell Proliferation and Parathyroid Hormone Secretion"],"prefix":"10.1158","volume":"64","author":[{"given":"Hideaki","family":"Sowa","sequence":"first","affiliation":[{"name":"1Division of Endocrinology\/Metabolism, Neurology and Hematology\/Oncology, Department of Clinical Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kaji","sequence":"additional","affiliation":[{"name":"1Division of Endocrinology\/Metabolism, Neurology and Hematology\/Oncology, Department of Clinical Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Kitazawa","sequence":"additional","affiliation":[{"name":"2Division of Molecular Pathology, Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Kitazawa","sequence":"additional","affiliation":[{"name":"2Division of Molecular Pathology, Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"1Division of Endocrinology\/Metabolism, Neurology and Hematology\/Oncology, Department of Clinical Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yano","sequence":"additional","affiliation":[{"name":"1Division of Endocrinology\/Metabolism, Neurology and Hematology\/Oncology, Department of Clinical Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Tsukada","sequence":"additional","affiliation":[{"name":"3Tumor Endocrinology Project, National Cancer Center Research Institute, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Canaff","sequence":"additional","affiliation":[{"name":"4Departments of Medicine, Physiology, and Human Genetics, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey N.","family":"Hendy","sequence":"additional","affiliation":[{"name":"4Departments of Medicine, Physiology, and Human Genetics, McGill University and Royal Victoria Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"1Division of Endocrinology\/Metabolism, Neurology and Hematology\/Oncology, Department of Clinical Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[{"name":"1Division of Endocrinology\/Metabolism, Neurology and Hematology\/Oncology, Department of Clinical Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,3,16]]},"reference":[{"key":"2022061620132683100_B1","unstructured":"Arnold A, Shattuck TM, Mallya SM, et al Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res, 17(Suppl.2):\u2008N30-6, \u20082002."},{"key":"2022061620132683100_B2","doi-asserted-by":"crossref","unstructured":"Hsi E, Zukerberg LR, Yang WI, Arnold A. Cyclin D1 (PRAD1) expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab, 81:\u20081736-9, \u20081996.","DOI":"10.1210\/jcem.81.5.8626826"},{"key":"2022061620132683100_B3","doi-asserted-by":"crossref","unstructured":"Imanishi Y, Hosokawa Y, Yoshimoto K, et al Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Investig, 107:\u20081093-102, \u20082001.","DOI":"10.1172\/JCI10523"},{"key":"2022061620132683100_B4","doi-asserted-by":"crossref","unstructured":"Dotzenrath C, Teh BT, Farnebo F, et al Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?. J Clin Endocrinol Metab, 81:\u20083194-6, \u20081996.","DOI":"10.1210\/jcem.81.9.8784068"},{"key":"2022061620132683100_B5","doi-asserted-by":"crossref","unstructured":"Larsson C, Skogseid B, Oberg K, Nakamura T, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature (Lond.), 332:\u200885-7, \u20081988.","DOI":"10.1038\/332085a0"},{"key":"2022061620132683100_B6","doi-asserted-by":"crossref","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P, et al Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (Wash. DC), 276:\u2008404-7, \u20081997.","DOI":"10.1126\/science.276.5311.404"},{"key":"2022061620132683100_B7","doi-asserted-by":"crossref","unstructured":"Lemmens I, Van de Ven WJ, Kas K, et al Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet, 6:\u20081177-83, \u20081997.","DOI":"10.1093\/hmg\/6.7.1177"},{"key":"2022061620132683100_B8","doi-asserted-by":"crossref","unstructured":"Pannett AAJ, Thakker RV. Multiple endocrine neoplasia type 1. Endocr Relat Cancer, 6:\u2008449-73, \u20081999.","DOI":"10.1677\/erc.0.0060449"},{"key":"2022061620132683100_B9","unstructured":"Marx SJ, Agarwal SK, Kester MB, et al Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res, 5:\u2008397-439, \u20081999."},{"key":"2022061620132683100_B10","doi-asserted-by":"crossref","unstructured":"Heppner C, Kester MB, Agarwal SK, et al Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet, 16:\u2008375-8, \u20081997.","DOI":"10.1038\/ng0897-375"},{"key":"2022061620132683100_B11","doi-asserted-by":"crossref","unstructured":"Carling T, Correa P, Hessman O, et al Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab, 83:\u20082960-3, \u20081998.","DOI":"10.1210\/jc.83.8.2960"},{"key":"2022061620132683100_B12","doi-asserted-by":"crossref","unstructured":"Farnebo F, Teh B, Kytola S, et al Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab, 83:\u20082627-30, \u20081998.","DOI":"10.1210\/jc.83.8.2627"},{"key":"2022061620132683100_B13","doi-asserted-by":"crossref","unstructured":"Kim YS, Burns AL, Goldsmith PK, et al Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene, 18:\u20085936-42, \u20081999.","DOI":"10.1038\/sj.onc.1203005"},{"key":"2022061620132683100_B14","doi-asserted-by":"crossref","unstructured":"Crabtree JS, Scacheri PC, Ward JM, et al A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA, 98:\u20081118-23, \u20082001.","DOI":"10.1073\/pnas.98.3.1118"},{"key":"2022061620132683100_B15","doi-asserted-by":"crossref","unstructured":"Bertolino P, Tong WM, Galendo D, Wang ZQ, Zhang CX. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol Endocrinol, 17:\u20081880-92, \u20082003.","DOI":"10.1210\/me.2003-0154"},{"key":"2022061620132683100_B16","doi-asserted-by":"crossref","unstructured":"Kaji H, Canaff L, Lebrun J-J, Goltzman D, Hendy GN. Inactivation of menin, a Smad3-interacting protein, blocks TGF-\u03b2 signaling. Proc Natl Acad Sci USA, 98:\u20083837-42, \u20082001.","DOI":"10.1073\/pnas.061358098"},{"key":"2022061620132683100_B17","doi-asserted-by":"crossref","unstructured":"Sowa H, Kaji H, Canaff L, et al Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J Biol Chem, 278:\u200821058-69, \u20082003.","DOI":"10.1074\/jbc.M302044200"},{"key":"2022061620132683100_B18","unstructured":"Kaji H, Canaff L, Goltzman D, Hendy GN. Cell cycle regulation of menin expression. Cancer Res, 59:\u20085097-101, \u20081999."},{"key":"2022061620132683100_B19","doi-asserted-by":"crossref","unstructured":"Poisson A, Zabelwska B, Gaudray P. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Lett, 189:\u20081-10, \u20082003.","DOI":"10.1016\/S0304-3835(02)00509-8"},{"key":"2022061620132683100_B20","doi-asserted-by":"crossref","unstructured":"De Caestecker MP, Piek E, Roberts AB. Role of transforming growth factor-\u03b2 signaling in cancer. J Natl Cancer Inst (Bethesda), 92:\u20081388-1402, \u20082000.","DOI":"10.1093\/jnci\/92.17.1388"},{"key":"2022061620132683100_B21","doi-asserted-by":"crossref","unstructured":"Hata A. TGF-\u03b2 signaling and cancer. Exp Cell Res, 264:\u2008111-6, \u20082001.","DOI":"10.1006\/excr.2000.5140"},{"key":"2022061620132683100_B22","doi-asserted-by":"crossref","unstructured":"Togashi K, Takahashi N, Ando K, Tsukamoto Y, Marumo F. Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism. Int J Artif Organs, 13:\u200877-82, \u20081990.","DOI":"10.1177\/039139889001300204"},{"key":"2022061620132683100_B23","doi-asserted-by":"crossref","unstructured":"Shimizu S, Tsukada T, Futami H, et al Germline mutations of the MEN1 gene in Japanese kindreds with multiple endocrine neoplasia type 1. Jpn J Cancer Res, 88:\u20081029-32, \u20081997.","DOI":"10.1111\/j.1349-7006.1997.tb00325.x"},{"key":"2022061620132683100_B24","doi-asserted-by":"crossref","unstructured":"Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA, 68:\u2008820-3, \u20081971.","DOI":"10.1073\/pnas.68.4.820"},{"key":"2022061620132683100_B25","doi-asserted-by":"crossref","unstructured":"Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS. p21WAF1 and TGF-\u03b1 mediate parathyroid growth arrest by vitamin D and calcium. Kidney Int, 60:\u20082109-17, \u20082001.","DOI":"10.1046\/j.1523-1755.2001.00042.x"},{"key":"2022061620132683100_B26","doi-asserted-by":"crossref","unstructured":"Fujii Y, Moreira JE, Orlando C, et al Endothelin as an autocrine factor in the regulation of parathyroid cells. Proc Natl Acad Sci USA, 88:\u20084235-9, \u20081991.","DOI":"10.1073\/pnas.88.10.4235"},{"key":"2022061620132683100_B27","doi-asserted-by":"crossref","unstructured":"Kanesaka Y, Tokunaga H, Iwashita K, et al Endothelin receptor antagonist prevents parathyroid cell proliferation of low calcium diet-induced hyperparathyroidism in rats. Endocrinology, 142:\u2008407-13, \u20082001.","DOI":"10.1210\/endo.142.1.7884"},{"key":"2022061620132683100_B28","doi-asserted-by":"crossref","unstructured":"Gogusev J, Duchambon P, Stoermann-Chopard C, et al De novo expression of transforming growth factor-\u03b1 in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant, 11:\u20082155-62, \u20081996.","DOI":"10.1093\/oxfordjournals.ndt.a027131"},{"key":"2022061620132683100_B29","doi-asserted-by":"crossref","unstructured":"Sadler GP, Jones DL, Woodhead JS, Horgan K, Wheeler MH. Effect of growth factors on growth of bovine parathyroid cells in serum-free medium. World J Surg, 20:\u2008822-9, \u20081996.","DOI":"10.1007\/s002689900125"},{"key":"2022061620132683100_B30","doi-asserted-by":"crossref","unstructured":"Lambert D, Eaton CL, Harrison BJ. Fibroblast growth factors and their receptors in parathyroid disease. World J Surg, 22:\u2008520-5, \u20081998.","DOI":"10.1007\/s002689900429"},{"key":"2022061620132683100_B31","doi-asserted-by":"crossref","unstructured":"Tanaka R, Tsushima T, Murakami H, Shizume K, Obara T. Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors. World J Surg, 18:\u2008635-41, \u20081994.","DOI":"10.1007\/BF00353784"},{"key":"2022061620132683100_B32","doi-asserted-by":"crossref","unstructured":"Tang B, Bottinger EP, Jakowlew SB, et al Transforming growth factor-\u03b21 is a new form of tumor suppressor with true haploid insufficiency. Nat Med, 4:\u2008802-7, \u20081998.","DOI":"10.1038\/nm0798-802"},{"key":"2022061620132683100_B33","doi-asserted-by":"crossref","unstructured":"Ewan KB, Shyamala G, Ravani SA, et al Latent transforming growth factor-\u03b2 activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol, 160:\u20082081-93, \u20082002.","DOI":"10.1016\/S0002-9440(10)61158-3"},{"key":"2022061620132683100_B34","unstructured":"Bottinger EP, Jakubczak JL, Haines DC, Bagnall K, Wakefield LM. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor \u03b2 receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Cancer Res, 57:\u20085564-70, \u20081997."},{"key":"2022061620132683100_B35","doi-asserted-by":"crossref","unstructured":"Minami S, Sarkar DK. Transforming growth factor-\u03b21 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of estrogen-treated Fischer 344 rats. Neurochem Int, 30:\u2008499-506, \u20081997.","DOI":"10.1016\/S0197-0186(96)00087-3"},{"key":"2022061620132683100_B36","doi-asserted-by":"crossref","unstructured":"Delidow BC, Billis WM, Agarwal P, White BA. Inhibition of prolactin gene transcription by transforming growth factor-\u03b2 in GH3 cells. Mol Endocrinol, 5:\u20081716-22, \u20081991.","DOI":"10.1210\/mend-5-11-1716"},{"key":"2022061620132683100_B37","doi-asserted-by":"crossref","unstructured":"Tan SK, Wang FF, Pu HF, Liu TC. Differential effect of age on transforming growth factor-\u03b21 inhibition of prolactin gene expression versus secretion in rat anterior pituitary cells. Endocrinology, 138:\u2008878-85, \u20081997.","DOI":"10.1210\/endo.138.3.4996"},{"key":"2022061620132683100_B38","doi-asserted-by":"crossref","unstructured":"Arnold A, Brown MF, Urena P, et al Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Investig, 95:\u20082047-53, \u20081995.","DOI":"10.1172\/JCI117890"},{"key":"2022061620132683100_B39","doi-asserted-by":"crossref","unstructured":"Farnebo F, Teh BT, Dotzenrath C, et al Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Hum Genet, 99:\u2008342-9, \u20081997.","DOI":"10.1007\/s004390050369"},{"key":"2022061620132683100_B40","doi-asserted-by":"crossref","unstructured":"Tahara H, Imanishi Y, Yamada T, et al Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia. J Clin Endocrinol Metab, 85:\u20084113-7, \u20082000.","DOI":"10.1210\/jc.85.11.4113"},{"key":"2022061620132683100_B41","doi-asserted-by":"crossref","unstructured":"Shan L, Nakamura Y, Murakami M, et al Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality. Jpn J Cancer Res, 90:\u2008965-9, \u20081999.","DOI":"10.1111\/j.1349-7006.1999.tb00842.x"},{"key":"2022061620132683100_B42","doi-asserted-by":"crossref","unstructured":"Forsberg L, Villablanca A, Valimaki S, et al Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism. Eur J Endocrinol, 145:\u2008415-20, \u20082001.","DOI":"10.1530\/eje.0.1450415"},{"key":"2022061620132683100_B43","doi-asserted-by":"crossref","unstructured":"Imanishi Y, Tahara H, Palanisamy N, et al Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism in uremia. J Am Soc Nephrol, 13:\u20081490-8, \u20082002.","DOI":"10.1097\/01.ASN.0000018148.50109.C0"},{"key":"2022061620132683100_B44","doi-asserted-by":"crossref","unstructured":"Sayo Y, Murao K, Imachi H, et al The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology, 143:\u20082437-40, \u20082002.","DOI":"10.1210\/endo.143.6.8950"},{"key":"2022061620132683100_B45","doi-asserted-by":"crossref","unstructured":"Nanihara H, Sato M, Murao K, et al The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity. J Mol Endocrinol, 29:\u2008297-304, \u20082002.","DOI":"10.1677\/jme.0.0290297"},{"key":"2022061620132683100_B46","unstructured":"Libutti SK, Crabtree JS, Lorang D, et al Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res, 63:\u20088022-8, \u20082003."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/6\/2222\/2523725\/zch00604002222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/6\/2222\/2523725\/zch00604002222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T21:00:05Z","timestamp":1655413205000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/6\/2222\/512347\/Menin-Inactivation-Leads-to-Loss-of-Transforming"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,15]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,3,16]]},"published-print":{"date-parts":[[2004,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-3334","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,15]]}}}